An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Clinically significant stress urinary incontinence

Exclusion Criteria:

• History or evidence of any relevant confounding urological or neurological disease